Collard Craig A — SEC insider filings
SEC reporting owner CIK 1363558. 49 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 49 filings on record, filed 2021-06-09 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 9 filings — 392,116 shares, $1,137,843 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 90.
- Largest priced transaction: purchase of 27,150 shares @ $13.54 ($367,611) in OPIANT PHARMACEUTICALS, INC., filed 2022-05-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OPIANT PHARMACEUTICALS, INC. (OPNT) | Director | 8 | 6 legs · 48,616 sh · $689,010 | — | 11 |
| Sierra Oncology, Inc. (SRRA) | Director | 3 | 2 legs · 13,500 sh · $310,863 | — | 4 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Chief Executive Officer, Director | 28 | 1 leg · 150,000 sh · $137,970 | — | 62 |
| TerrAscend Corp. (TSNDF) | Director | 10 | 2 legs · 180,000 sh | — | 13 |
Insider filings — Collard Craig A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 50,021 · Tax withholding (F): 12,181 @ $0.28 · Option exercise (M): 34,788 · Tax withholding (F): 8,471 @ $0.28 · Option exercise (M): 50,021 (derivative) @ $0 · Option exercise (M): 34,788 (derivative) @ $0 | EDGAR |
| 2026-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Tax withholding (F): 3,360 @ $0.36 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 50,021 · Option exercise (M): 34,789 · Option exercise (M): 50,021 (derivative) @ $0 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | TerrAscend Corp. (TSNDF) | Disposition to issuer (D): 150,000 (derivative) · Grant/award (A): 150,000 (derivative) | EDGAR |
| 2026-05-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 34,789 · Option exercise (M): 50,021 · Option exercise (M): 34,789 (derivative) @ $0 · Option exercise (M): 50,021 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 800,337 (derivative) @ $0 · Grant/award (A): 800,336 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | TerrAscend Corp. (TSNDF) | Grant/award (A): 433,653 @ $0 | EDGAR |
| 2025-05-02 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,796 · Option exercise (M): 13,796 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | TerrAscend Corp. (TSNDF) | Tax withholding (F): 2,258 @ $0.46 | EDGAR |
| 2025-02-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 1,113,240 (derivative) @ $0 · Grant/award (A): 556,620 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | TerrAscend Corp. (TSNDF) | Tax withholding (F): 71,704 @ $0.65 | EDGAR |
| 2024-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | TerrAscend Corp. (TSNDF) | Grant/award (A): 163,334 @ $0 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 1,324,502 (derivative) @ $0 · Grant/award (A): 220,750 (derivative) @ $0 | EDGAR |
| 2023-11-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Purchase (P): 150,000 @ $0.92 | EDGAR |
| 2023-08-24 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Tax withholding (F): 692 @ $1.65 | EDGAR |
| 2023-06-26 | 4 | TerrAscend Corp. (TRSSF) | Grant/award (A): 132,647 @ $0 | EDGAR |
| 2023-05-24 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Tax withholding (F): 691 @ $1.45 | EDGAR |
| 2023-04-05 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 3,000,000 (derivative) @ $0 · Grant/award (A): 250,000 (derivative) @ $0 · Grant/award (A): 4,250,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Disposition to issuer (D): 53,822 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2022-09-27 | 4 | TerrAscend Corp. (TRSSF) | Purchase (P): 60,000 | EDGAR |
| 2022-09-26 | 4 | TerrAscend Corp. (TRSSF) | Purchase (P): 120,000 | EDGAR |
| 2022-07-01 | 4 | Sierra Oncology, Inc. (SRRA) | Disposition to issuer (D): 13,500 @ $55 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 | EDGAR |
| 2022-06-29 | 4 | TerrAscend Corp. (TRSSF) | Grant/award (A): 36,496 · Grant/award (A): 77,918 | EDGAR |
| 2022-06-14 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-13 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Purchase (P): 1,663 @ $11.50 · Purchase (P): 4,037 @ $10.94 | EDGAR |
| 2022-05-17 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Purchase (P): 27,150 @ $13.54 | EDGAR |
| 2022-05-16 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Purchase (P): 3,689 @ $10.49 | EDGAR |
| 2022-01-10 | 4 | TerrAscend Corp. (TRSSF) | Option exercise/expiry (X): 52,939 @ $2.54 · Option exercise/expiry (X): 52,939 (derivative) @ $0 | EDGAR |
| 2021-11-24 | 4 | Sierra Oncology, Inc. (SRRA) | Purchase (P): 5,601 @ $22.95 · Purchase (P): 7,899 @ $23.09 | EDGAR |
| 2021-09-15 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Purchase (P): 2,500 @ $18.13 · Grant/award (A): 506 @ $17.96 · Grant/award (A): 700 @ $18.07 | EDGAR |
| 2021-09-13 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Purchase (P): 9,577 @ $18.18 | EDGAR |
| 2021-06-16 | 4 | OPIANT PHARMACEUTICALS, INC. (OPNT) | Grant/award (A): 2,000 @ $0 · Grant/award (A): 2,500 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | Sierra Oncology, Inc. (SRRA) | Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-05-24 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1363558 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs